Ambu recalls single-use product one year after launch

A number of complaints concerning an Ambu product which was approved in the US and EU last year have led the medtech firm to withdraw the product from the market and ask customers to destroy any stock of the product they have.
Photo: PR / Ambu
Photo: PR / Ambu
by ulrich quistgaard, translated by catherine brett

After just one year on the market, Ambu has been forced to recall its Vivasight 2 DLT product.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading